Clinical Trial Update: Safety Study of BMS-823778 in Subjects With Type 2 Diabetes [Phase 2]

View source ↗

Summary

Phase 2 safety study of BMS-823778 in adults with type 2 diabetes has completed; results summarized in this update.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Type 2 Diabetes Mellitus

Drugs mentioned

• BMS-823778

Snippet

Sponsor: Bristol-Myers Squibb | Conditions: Diabetes Mellitus, Type 2 | Phase 2 | Status: COMPLETED